Januvia and Sinusitis - chronic - a phase IV clinical study of FDA data

Summary:

Sinusitis - chronic is reported as a side effect among people who take Januvia (sitagliptin phosphate), especially for people who are female, 60+ old, have been taking the drug for 2 - 5 years also take Aspirin, and have Multiple sclerosis.

The phase IV clinical study analyzes which people have Sinusitis - chronic when taking Januvia. It is created by eHealthMe based on reports of 71,642 people who have side effects when taking Januvia from the FDA, and is updated regularly.

What is Januvia?

Januvia has active ingredients of sitagliptin phosphate. It is often used in diabetes. eHealthMe is studying from 72,818 Januvia users. Check the latest studies of Januvia.

What is Sinusitis - chronic?

Sinusitis - chronic is found to be associated with 1,004 drugs and 760 conditions by eHealthMe. Check the latest studies of Sinusitis - chronic.



On Aug, 09, 2026

71,642 people reported to have side effects when taking Januvia.
Among them, 39 people (0.05%) have Sinusitis - chronic.

Could Januvia cause Sinusitis - chronic?

Among these 39 people:

How long have people been on Januvia when they have Sinusitis - chronic? *

  • < 1 month: 10 %
  • 1 - 6 months: 30 %
  • 6 - 12 months: 0.0 %
  • 1 - 2 years: 20 %
  • 2 - 5 years: 40 %
  • 5 - 10 years: 0.0 %
  • 10+ years: 0.0 %

What is the gender of people who have Sinusitis - chronic when taking Januvia? *

  • female: 82.05 %
  • male: 17.95 %

What is the age of people who have Sinusitis - chronic when taking Januvia? *

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 0.0 %
  • 40-49: 18.18 %
  • 50-59: 36.36 %
  • 60+: 45.45 %

What are other drugs people take besides Januvia? *

  1. Aspirin: 12 people, 30.77%
  2. Vitamin D3: 11 people, 28.21%
  3. Alprazolam: 10 people, 25.64%
  4. Synthroid: 10 people, 25.64%
  5. Imdur: 8 people, 20.51%
  6. Biotin: 8 people, 20.51%
  7. Phenergan: 8 people, 20.51%
  8. Premarin: 8 people, 20.51%
  9. Aredia: 8 people, 20.51%
  10. Zometa: 8 people, 20.51%

What are other side effects people have besides Sinusitis - chronic? *

  1. Depression: 26 people, 66.67%
  2. Haemorrhoids (a swollen vein or group of veins in the region of the anus): 17 people, 43.59%
  3. Infection: 16 people, 41.03%
  4. Cough: 15 people, 38.46%
  5. Arthropathy: 15 people, 38.46%
  6. Osteoarthritis (a joint disease caused by cartilage loss in a joint): 14 people, 35.90%
  7. Joint Pain: 14 people, 35.90%
  8. Headache (pain in head): 13 people, 33.33%
  9. Hiatal Hernia (hernia resulting from the protrusion of part of the stomach through the diaphragm): 13 people, 33.33%
  10. Asthma: 12 people, 30.77%

What are the existing conditions these people have? *

  1. Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 9 people, 23.08%
  2. Multiple Myeloma (cancer of the plasma cells): 8 people, 20.51%
  3. Bladder Disorder: 7 people, 17.95%
  4. Pain: 7 people, 17.95%
  5. Urethritis Noninfective (inflammation of the urethra - non infective): 7 people, 17.95%
  6. Blood Glucose Abnormal: 7 people, 17.95%
  7. Gait Disturbance: 7 people, 17.95%
  8. Cough: 7 people, 17.95%
  9. Immunodeficiency Common Variable: 4 people, 10.26%
  10. Diarrhea: 3 people, 7.69%

* Approximation only. Some reports may have incomplete information.

Do you take Januvia and have Sinusitis - chronic?

- Check whether Sinusitis - chronic is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, long term effects of, and alternative drugs to Januvia:

Sinusitis - chronic treatments and more:

How severe was Sinusitis - chronic and when was it recovered:

Expand to all the drugs that have ingredients of sitagliptin phosphate:

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Januvia:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Sinusitis - chronic:

Browse all the conditions that are associated with Sinusitis - chronic:

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on sitagliptin phosphate (the active ingredients of Januvia) and Januvia (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: